|
Volumn 15, Issue 1, 2008, Pages 1-2
|
Targeting TGF-β and the Extracellular Matrix in Marfan's Syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
FIBRILLIN 1;
LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN;
LOSARTAN;
NEUTRALIZING ANTIBODY;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA ANTIBODY;
VASCULOTROPIN;
AORTA ANEURYSM;
AORTA DISSECTION;
AORTA ROOT;
AUTOSOMAL DOMINANT DISORDER;
CAUSE OF DEATH;
COMBINATION CHEMOTHERAPY;
COMPLEX FORMATION;
CONNECTIVE TISSUE DISEASE;
COVALENT BOND;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DRUG EFFICACY;
DRUG TARGETING;
EXTRACELLULAR MATRIX;
GENE MUTATION;
GROWTH RETARDATION;
HUMAN;
MARFAN SYNDROME;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
CHILD;
DISEASE PROGRESSION;
EXTRACELLULAR MATRIX;
GENES, DOMINANT;
HUMANS;
LOSARTAN;
MARFAN SYNDROME;
MICROFILAMENT PROTEINS;
MUTATION;
SIGNAL TRANSDUCTION;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 46049089987
PISSN: 15345807
EISSN: None
Source Type: Journal
DOI: 10.1016/j.devcel.2008.06.005 Document Type: Short Survey |
Times cited : (18)
|
References (10)
|